- Home
- NVO vs PANW Comparison
NVO vs PANW Comparison
Compare NVO & PANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | PANW |
|---|---|---|
| Founded | 1923 | 2005 |
| Country | Denmark | United States |
| Employees | 69500 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.4B | 173.3B |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | NVO | PANW |
|---|---|---|
| Price | $42.90 | $271.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 39 |
| Target Price | $51.00 | ★ $216.28 |
| AVG Volume (30 Days) | ★ 10.9M | 9.0M |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | ★ 3.19% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $2,273,100,000.00 |
| Revenue This Year | N/A | $24.93 |
| Revenue Next Year | $3.70 | $19.97 |
| P/E Ratio | ★ $13.60 | $353.56 |
| Revenue Growth | N/A | ★ 29.04 |
| 52 Week Low | $35.12 | $139.57 |
| 52 Week High | $81.44 | $302.95 |
Technical Indicators
Market Signals| Indicator | NVO | PANW |
|---|---|---|
| Relative Strength Index (RSI) | 46.75 | 64.09 |
| Support Level | $35.49 | $179.81 |
| Resistance Level | $50.30 | N/A |
| Average True Range (ATR) | 1.15 | 12.98 |
| MACD | -0.45 | 0.34 |
| Stochastic Oscillator | 27.11 | 53.54 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three-fourths of the Global 2000.